EPISODE · Dec 2, 2025 · 5 MIN
A Randomized Clinical Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Acute Coronary Syndrome Patients: The TARGET-D Trial - report from AHA 2025
from Medical Digest & Congress Report · host Medical Congress News
Professor Heidi T. May explains heart attack risk halved in adults with heart disease taking tailored vitamin D doses at AHA Scientific Sessions 2025.Video: https://medicaldigest.org/scientific-contents/interview:randomized-clinical-trial-evaluating-vitamin-d-normalization-major-adverse-cardiovascular-related-events-among-acute-coronary-syndrome-patients-target-d-trial
Embed this episode
NOW PLAYING
A Randomized Clinical Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Acute Coronary Syndrome Patients: The TARGET-D Trial - report from AHA 2025
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.